Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study

Medication-overuse headache (MOH) represents a severely disabling condition, with a low response to prophylactic treatments. Recently, consistent evidences have emerged in favor of botulinum toxin type-A (onabotulinum toxin A) as prophylactic treatment in chronic migraine. In a 12-week double-blind,...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Sandrini, Giorgio, Perrotta, Armando, Tassorelli, Cristina, Torelli, Paola, Brighina, Filippo, Sances, Grazia, Nappi, Giuseppe
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer Milan 2011
Pynciau:
Original
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3139089/
https://ncbi.nlm.nih.gov/pubmed/21499747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10194-011-0339-z
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg